Attorneys general in 42 states said they finalized a $700 million settlement with Johnson & Johnson over the marketing of its talcum powder products. The settlement, announced in principle in January, resolves an investigation by the states and Washington D.C. …
Johnson & Johnson must pay $260 million to an Oregon woman who said she got mesothelioma, a deadly cancer linked to asbestos exposure, from inhaling the company’s talc powder, a jury found on Monday. The verdict in the 4th Judicial …
Johnson & Johnson has tentatively agreed to pay about $700 million to resolve an investigation by more than 40 US states of claims that it wrongfully marketed its talc-based baby powder by not warning about possible health risks, according to …
Johnson & Johnson said it’s moving forward to resolve lawsuits that claim its talc-based Baby Powder causes cancer to avoid facing some jury trials next year and further its strategy of finding a global settlement for thousands of cases. “We …
Johnson & Johnson said it is weighing a third attempt to use bankruptcy for an $8.9 billion settlement of tens of thousands of lawsuits that allege tainted talc in the company’s baby powder caused cancer. Erik Haas, J&J’s lawyer in …
A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company’s talc powder …
NEW YORK —Lawyers for thousands of people who claim Johnson & Johnson’s talc-based powders caused them to develop cancer on Wednesday urged a U.S. judge to temporarily block the company from seeking bankruptcy protection for a third time for its …
Lawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson’s JNJ.N talc-based baby powder on Monday urged a jury to order the company to pay heavy punitive damages, calling its …
Johnson & Johnson’s second attempt to resolve talc lawsuits in bankruptcy should be dismissed as an unprecedented fraud designed to deny plaintiffs just compensation, lawyers representing cancer victims argued in a Monday court filing. The attorneys contend J&J defied a …
Johnson & Johnson’s shares rose nearly 4% in early trading to hit a near two-month high of $164.48 on Wednesday as the company’s $8.9 billion offer to settle talc-related lawsuits gained support of thousands of claimants, easing an overhang on …